A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
Sponsored by Eli Lilly and Company
About this study
The purpose of this study is to measure the change in hemoglobin A1c (HbA1c) with LY3457263 compared with placebo in participants with type 2 diabetes who are not at HbA1c goal when treated with a stable dose of semaglutide or tirzepatide. Participation in the study will last about 9 months.
Where this study is enrolling (24)
- I'm interested
Helios Clinical Research - Phoenix
Phoenix, Arizona
- Call 714-617-2426
Wolverine Clinical Trials
Santa Ana, California
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 407-977-2705
Oviedo Medical Research
Oviedo, Florida
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 3526295800
Renstar Medical Research
Ocala, Florida
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 6784945735
North Georgia Clinical Research
Woodstock, Georgia
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
Show all 24 locations
- Call 770-696-4541
Balanced Life Health Care Solutions/SKYCRNG
Lawrenceville, Georgia
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 470-317-3604
Rophe Adult and Pediatric Medicine/SKYCRNG
Union City, Georgia
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 678-252-2375
Physicians Research Associates
Lawrenceville, Georgia
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 208 356-8977
Elite Clinical Trials
Rexburg, Idaho
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 3178528280
Investigators Research Group
Brownsburg, Indiana
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 215-676-6696
Clinical Research of Philadelphia
Pennington, New Jersey
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 516-574-9232
NYC Research INC
Long Island City, New York
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 7167121004
Southgate Medical Group
West Seneca, New York
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 252-222-5700
Lucas Research, Inc.
Morehead City, North Carolina
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 9805529230
Shelby Clinical Research
Shelby, North Carolina
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 937-297-8994
Providence Health Partners-Center for Clinical Research
Dayton, Ohio
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 4057018999
Alliance for Multispecialty Research, LLC
Norman, Oklahoma
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 724-220-5281
Frontier Clinical Research, LLC
Scottdale, Pennsylvania
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call (713) 779-5494
Juno Research
Houston, Texas
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 214-693-0904
Southern Endocrinology Associates
Mesquite, Texas
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 210-545-4900
Consano Clinical Research, LLC
Shavano Park, Texas
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 512-334-3505
Texas Diabetes & Endocrinology, P.A.
Round Rock, Texas
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 956-431-8090
Texas Valley Clinical Research
Weslaco, Texas
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 4258696828
Eastside Research Associates
Redmond, Washington
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
Who can participate
Inclusion criteria
- ✓Have type 2 diabetes
- ✓Have HbA1c ≥7.5% to ≤10.5% at screening
- ✓Have a body mass index (BMI) of ≥27 kilograms per square meter (kg/m2) at screening
- ✓Have had a stable body weight for the three months prior to screening
- ✓On stable treatment dose of one of the following incretins for at least three months prior to screening:
- ✓Injectable semaglutide (1 and 2 milligram (mg))
- ✓Injectable tirzepatide (5, 7.5, 10, 12.5 and 15 mg)
Exclusion criteria
- ✕Have type 1 diabetes, latent autoimmune diabetes, or history of ketoacidosis or hyperosmolar coma
- ✕Have a prior or planned surgical treatment for obesity
- ✕Have any of the following cardiovascular conditions within three months prior to screening:
- ✕acute myocardial infarction
- ✕cerebrovascular accident (stroke)
- ✕unstable angina, or
- ✕hospitalization due to congestive heart failure
- ✕Have used insulin to control blood glucose within the past year (short-term use allowed)
- ✕Current use of prohibited oral antihyperglycemic medication (OAM) (including but not limited to, Dipeptidyl Peptidase IV Inhibitors (DPP-4i) and meglitinides) may be randomized if the prohibited OAM treatment was discontinued at least 3 months prior to screening
- ✕If participant has been on stable doses (for at least three months) of up to three permitted OAMs (limited to metformin, sodium-glucose cotransporter-2 (SGLT2) inhibitors, alpha-glucosidase inhibitors, sulfonylurea, and/or thiazolidinediones (TZD), they are permitted to participate in the study
- ✕Have taken any medications or alternative remedies for weight loss within three months prior to screening
Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.